Claude H. Nash Mark A. McKinlay Marc S. Collett Johanna A. Griffin Guy D. Diana
Defunct
2014
Headquarters
Exton, Pennsylvania, U.S.
Key people
Vincent Milano (Chairman and CEO)
Products
Vancocin
Revenue
132,417,000 USD (2005)
Operating income
88,145,000 USD (2005)
Net income
113,705,000 USD (2005)
Number of employees
232[1]
Website
www.viropharma.com
ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on viruses and human disease, including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections. It was purchased by Shire in 2013, with Shire paying around $4.2 billion for the company in a deal that was finalized in January 2014.[2] ViroPharma was a member of the NASDAQ Biotechnology Index and the S&P 600.
The company had strategic relationships with GlaxoSmithKline, Schering-Plough, and Sanofi-Aventis. ViroPharma acquired Lev Pharmaceuticals in a merger in 2008.[3][4]
^"Symbol Lookup from Yahoo Finance". finance.yahoo.com.
^"Shire acquires ViroPharma for $4.2bn". Financier Worldwide. Retrieved 23 April 2020.
^Staff (15 July 2008). "ViroPharma to Purchase Lev for $442.9M". Genetic Engineering & Biotechnology News. GEN News Highlights. Mary Ann Liebert. ISSN 1937-8661. Retrieved 26 September 2008.
^"Lev Pharmaceuticals Investor Relations". Lev Pharmaceuticals. Retrieved 8 April 2009.
and Schering-Plough" (PDF). Retrieved 23 December 2023. The Long Road Ahead for ViroPharma Motley Fool 29 September 2006 Companies portal viropharma.com...
announced it had entered into a three-year collaboration with Mitsubishi Tanabe Pharma on diabetic nephropathy. In September 2014 the company would join forces...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
failed The Blum Store Philadelphia women’s clothing and accessories failed ViroPharma Exton, PA pharmaceuticals acquired by Shire Wanamaker's Philadelphia retail...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
maribavir may reduce their antiviral activity. Maribavir is licensed by ViroPharma from GlaxoSmithKline in 2003, for the prevention and treatment of human...
2013. Retrieved 30 May 2013. "Research-based pharma pledges on neglected tropical diseases". The Pharma Letter. 31 January 2012. Archived from the original...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
Outfitters USA 3000 Airlines U.S. Steel USF Glen Moore The Vanguard Group ViroPharma Vishay Intertechnology VWR International Weis Markets WESCO International...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
CEO of Procter & Gamble Claude H. Nash, cofounded, CEO, and chairman of ViroPharma Incorporated and CEO of Bloodstone Ventures Soni Oyekan, chemical engineer...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...
Susquehanna International Group Vanguard Toll Brothers Triumph Group Unisys ViroPharma Vishay Intertechnology VWR Wawa Wilmington Trust W. L. Gore & Associates...